Analysis explores immune dysfunction in keloids, suggesting new treatment strategies for better outcomes.
Immunoregulatory mechanisms and cytotoxic immune dysfunction are central to keloid pathogenesis. Targeting these pathways may provide a basis for the development of novel immunomodulatory strategies to improve keloid outcomes.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: